Raphael Pharmaceutical Inc. cotiza a 1.40 USD y tiene una capitalización bursátil de $28M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-bas…
| Métrica | RAPH | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -2413.2% | -32.0% | -2381.2% |
| Current Ratio | 0.03 | 2.84 | -2.81 |
| Debt / Equity | — | 0.28 | — |